Pacira BioSciences, Inc. — Director's Dealing 2018

Jan 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2018-01-03

Reporting Person: Braunstein Scott (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-03	Stock Option (Right to Buy)	$46.35	A	60000	Acquired	2028-01-03	Common Stock (60000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.